Government approves strategic sale of IMPCL to Skymap Pharmaceuticals for Rs 121 crore

Government approves IMPCL strategic sale to Skymap Pharmaceuticals for Rs 121 crore under competitive bidding as part of India’s disinvestment plan.

Raccontata dathehindubusinessline.com